Omemyl (Omeprazole)

Omeprazole, the active ingredient in Omemyl, is a Proton Pump Inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Omemyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omemyl is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): Provides relief of heartburn and promotes healing of esophageal erosion. - Peptic ulcer disease: Facilitates ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: Controls excessive gastric acid secretion associated with the condition.

Adverse reactions to Omeprazole may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatic stress. - Acute interstitial nephritis: kidney inflammation.

When using Omemyl, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe renal impairment. - Evaluate hepatic function: use with caution in patients with liver disease. - Monitor long‑term use: prolonged therapy may increase fracture risk. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: weigh benefits against potential risks; consult healthcare provider. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can interact with several medicines, requiring attention to the interaction severity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular event risk. - Atazanavir: decreased antiviral absorption, compromising HIV treatment. - Methotrexate: increased serum levels, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Phenytoin: possible reduction in serum concentration. - Digoxin: may increase serum concentration. - Diazepam: enhanced sedative effect.